Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SunPine AB and its shareholders
Mandate

Vinge advises SunPine AB and its shareholders

December 06, 2012

Vinge has advised SunPine AB, a company conducting operations in the biodiesel industry and the company’s shareholders (Sveaskog Förvaltnings Aktiebolag (publ), Södra Skogsägarana co-operative association, Preem Aktiebolag (publ) and Kiram AB) in a joint venture with Lawter BVBA (a subsidiary of Harima Chemical Group Inc.) regarding the construction of a resin plant at SunPine’s facility in Piteå.

Vinge’s team consisted of, among others, partners Malin Ohlin and Christina Kokko and associates Christian Hybbinette, Claes Henriksson, Jonatan Lund Kirkhoff and Mårten Svensson. 

 

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025